Blood Flow Restriction and Exercise for Parkinson's Disease
(BFR-PD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine whether combining blood flow restriction (gently limiting blood flow with inflatable cuffs) and aerobic exercise can improve movement and quality of life for individuals with advanced Parkinson's disease. Participants will use a Nu-Step machine, a type of exercise equipment, twice a week for eight weeks under professional supervision. The trial seeks participants with advanced Parkinson's disease who can walk independently, even with a walking aid. As an unphased trial, this study offers a chance to contribute to innovative research that may enhance daily living for those with Parkinson's.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, it mentions that certain medical conditions and medications may require clearance from a healthcare provider to ensure safe participation.
What prior data suggests that this method is safe for people with Parkinson's disease?
Research has shown that blood flow restriction (BFR) training can be safely used by people with Parkinson's disease. One study found that BFR training improved strength and reduced symptoms like restless leg syndrome without major safety issues. However, some reports noted that BFR can cause increased pain, tiredness, and muscle soreness during exercise. Despite these concerns, BFR is generally considered a safe and effective way to build strength, especially under supervision. In middle-aged and older women, BFR training demonstrated benefits such as increased strength and lower blood pressure. While BFR appears promising, individuals should carefully consider their own health conditions before starting.12345
Why are researchers excited about this trial?
Researchers are excited about using blood flow restriction (BFR) with exercise for Parkinson's disease because it offers a novel approach to improving physical function. Unlike traditional treatments like medication or deep brain stimulation, which focus primarily on managing symptoms, this method aims to enhance muscle strength and endurance through a unique mechanism. By partially restricting blood flow during exercise, BFR may amplify the benefits of aerobic activities, potentially providing a safe and effective way to boost movement capabilities in individuals with Parkinson's. This approach could complement existing therapies, offering a promising new avenue for improving quality of life.
What evidence suggests that blood flow restriction and exercise might be an effective treatment for Parkinson's disease?
Studies have shown that combining blood flow restriction (BFR) with exercise can help people with Parkinson's disease become stronger and more functional. In this trial, participants will engage in aerobic exercise using a Nu-Step recumbent stepper combined with lower-extremity BFR. Special cuffs gently reduce blood flow to the legs during exercise, allowing people to build strength even with lighter workouts. Research indicates that this method can improve mobility and reduce symptoms like restless leg syndrome. Additionally, BFR training enhances balance and coordination, which are often challenging for those with Parkinson's. These findings suggest that BFR and exercise together could be a promising way to improve the quality of life for those with the condition.12367
Who Is on the Research Team?
Jessica Bath, DPT, PhD
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for people with advanced Parkinson's disease who can safely perform aerobic exercise. Participants will need to commit to twice-weekly training sessions for 8 weeks and complete surveys and tests. They should be able to use a Nu-Step machine with special cuffs that limit blood flow during exercise.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline assessments conducted individually with the PI, including consent and initial measurements
Treatment
Participants undergo 8 weeks of supervised aerobic stepping exercise with blood flow restriction, including weekly surveys and continuous monitoring
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of continued intervention effects and short-term durability
What Are the Treatments Tested in This Trial?
Interventions
- Blood Flow Restriction and Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor